This content is from: Patents

Kramer Levin adds two life sciences partners in New York

Brian Slater and Gregory Sephton have joined Kramer Levin Naftalis & Frankel in New York. They were previously at Fitzpatrick Cella Harper & Scinto

They both have more than 20 years of experience handling patent litigation involving a broad range of technologies in the life sciences.

Slater (top right) has served as lead counsel to companies such as Gilead, Merck, and Sanofi.

Sephton (bottom right) has been involved in litigating and trying patent cases for a number of technology leaders, including Emory University, Astra Zeneca, Novartis and Warner Chilcott.

The move follows Kramer Levin’s recent hiring of Christine Willgoos, a life sciences patent litigator who came from Paul Hastings.

The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2020 Euromoney Institutional Investor PLC. For help please see our FAQs.


Instant access to all of our content. Membership Options | One Week Trial